Sato Pharmaceutical to Market New Health Maintenance Food Rich with DHA and EPA.
Tokyo, Japan, Oct 22, 2005 - (JCNN JCNN Japan Corporate News Network ) - Sato Pharmaceutical announced on October 21 that it will begin marketing SATO DHA DHA docosahexaenoic acid.
DHA,
n.pr See acid, docosahexaenoic. , a new health food product, on November 1.
SATO DHA contains rich omega-3 unsaturated fatty acids unsaturated fatty acids,
n.pl the double- or triple-bonded fatty acids contained primarily in vegetable oils and fish, which remain liquid at room temperature; linked to a reduction in the risk of developing heart disease. like docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA EPA eicosapentaenoic acid.
EPA
abbr.
eicosapentaenoic acid
EPA,
n.pr See acid, eicosapentaenoic.
EPA,
n. ). The new product will be helpful for those who are concerned about their lifestyle habits, overweight and imbalanced diet.
The soft capsule product made of purified fish oil retails for 3,150 yen ($27) per unit (90 capsules).
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion